Significant Pathology Associated With Crossed Leg Sign

Pathology Clinical Trial

Official title:

Crossed Leg Sign and it's Correlation With Significant Pathology

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01569555
• Other study ID #: 7286
• Status: Not yet recruiting
• Phase: N/A
• First received: March 30, 2012
• Last updated: March 30, 2012
• Start date: May 2012
• Est. completion date: February 2013

Study information

• Verified date: March 2012
• Source: Uelk, J. Daniel, D.O.
• Contact: John D Uelk, DO
• Phone: 314-605-4486
• Email: juelk1[@]hfhs.org
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

By determining the correlation of a Crossed Leg Sign with signifcant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.

Description:

By determining the correlation of a Crossed Leg Sign with signifcant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology. Therefore, by determining the sensitivity and specificity of this physical exam finding, the clinician would have a better idea of the patients clinical management, including diagnostic testing and ultimate treatment of the patient. Crossed Leg Sign will be defined in this study as: any patient observed in the Emergency Department with sustained crossed legs. To my knowledge, crossed legs have never been evaluated in regards to it's correlation with significant pathology. This could potentially add another physical exam finding to be used by the clinician.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 400
• Est. completion date: February 2013
• Est. primary completion date: February 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Any patient observed in the Emergency Department with sustained crossed legs.

Exclusion Criteria:

• Any patient not observed to have sustained crossed legs and is not being used as a control.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pathology

Locations

Country	Name	City	State
United States	Henry Ford Wyandotte Hospital	Wyandotte	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
Uelk, J. Daniel, D.O.

Country where clinical trial is conducted

United States,